CN101653249B - 一种降血糖增强免疫力的功能食品 - Google Patents
一种降血糖增强免疫力的功能食品 Download PDFInfo
- Publication number
- CN101653249B CN101653249B CN200910094928XA CN200910094928A CN101653249B CN 101653249 B CN101653249 B CN 101653249B CN 200910094928X A CN200910094928X A CN 200910094928XA CN 200910094928 A CN200910094928 A CN 200910094928A CN 101653249 B CN101653249 B CN 101653249B
- Authority
- CN
- China
- Prior art keywords
- mouse
- hawthorn
- date
- functional food
- parts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 235000013376 functional food Nutrition 0.000 title claims abstract description 31
- 230000036039 immunity Effects 0.000 title claims abstract description 19
- 210000004369 blood Anatomy 0.000 title abstract description 31
- 239000008280 blood Substances 0.000 title abstract description 31
- 230000002708 enhancing effect Effects 0.000 title abstract description 5
- 241001092040 Crataegus Species 0.000 claims abstract description 27
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 27
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 27
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 27
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 27
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 27
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 27
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 27
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 27
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 27
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 27
- 240000004638 Dendrobium nobile Species 0.000 claims description 29
- 244000046146 Pueraria lobata Species 0.000 claims description 21
- 235000010575 Pueraria lobata Nutrition 0.000 claims description 21
- 230000002218 hypoglycaemic effect Effects 0.000 claims description 6
- 241001523681 Dendrobium Species 0.000 claims description 5
- 238000009835 boiling Methods 0.000 claims description 2
- 239000012141 concentrate Substances 0.000 claims description 2
- 239000002994 raw material Substances 0.000 claims description 2
- 238000001694 spray drying Methods 0.000 claims description 2
- 210000000952 spleen Anatomy 0.000 abstract description 13
- 230000036541 health Effects 0.000 abstract description 12
- 201000001421 hyperglycemia Diseases 0.000 abstract description 12
- 239000003814 drug Substances 0.000 abstract description 8
- 210000004185 liver Anatomy 0.000 abstract description 8
- 235000013305 food Nutrition 0.000 abstract description 6
- 210000001124 body fluid Anatomy 0.000 abstract description 5
- 239000010839 body fluid Substances 0.000 abstract description 5
- 238000004519 manufacturing process Methods 0.000 abstract description 5
- 235000013402 health food Nutrition 0.000 abstract description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract description 4
- 230000003647 oxidation Effects 0.000 abstract description 4
- 238000007254 oxidation reaction Methods 0.000 abstract description 4
- 208000024891 symptom Diseases 0.000 abstract description 4
- 230000029087 digestion Effects 0.000 abstract description 3
- 206010036067 polydipsia Diseases 0.000 abstract description 3
- 230000028327 secretion Effects 0.000 abstract description 3
- 102000004877 Insulin Human genes 0.000 abstract description 2
- 108090001061 Insulin Proteins 0.000 abstract description 2
- 206010037660 Pyrexia Diseases 0.000 abstract description 2
- 229940125396 insulin Drugs 0.000 abstract description 2
- 239000013589 supplement Substances 0.000 abstract 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 57
- 239000013642 negative control Substances 0.000 description 25
- 241000700159 Rattus Species 0.000 description 22
- 230000000694 effects Effects 0.000 description 21
- 230000006870 function Effects 0.000 description 19
- 241001465754 Metazoa Species 0.000 description 18
- 210000002966 serum Anatomy 0.000 description 18
- 206010012601 diabetes mellitus Diseases 0.000 description 17
- 210000002784 stomach Anatomy 0.000 description 16
- 238000012360 testing method Methods 0.000 description 15
- 230000000242 pagocytic effect Effects 0.000 description 13
- 210000001519 tissue Anatomy 0.000 description 13
- 235000009508 confectionery Nutrition 0.000 description 9
- 239000008103 glucose Substances 0.000 description 9
- 239000000796 flavoring agent Substances 0.000 description 8
- 235000019634 flavors Nutrition 0.000 description 8
- 230000003345 hyperglycaemic effect Effects 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- 102000019197 Superoxide Dismutase Human genes 0.000 description 7
- 108010012715 Superoxide dismutase Proteins 0.000 description 7
- 210000005013 brain tissue Anatomy 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 7
- 230000002440 hepatic effect Effects 0.000 description 7
- -1 lipid peroxide Chemical class 0.000 description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- 210000003024 peritoneal macrophage Anatomy 0.000 description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 5
- 108010006464 Hemolysin Proteins Proteins 0.000 description 5
- 239000003963 antioxidant agent Substances 0.000 description 5
- 230000003078 antioxidant effect Effects 0.000 description 5
- 235000006708 antioxidants Nutrition 0.000 description 5
- 229910052799 carbon Inorganic materials 0.000 description 5
- 230000007423 decrease Effects 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 150000004676 glycans Chemical class 0.000 description 5
- 239000003228 hemolysin Substances 0.000 description 5
- 210000004698 lymphocyte Anatomy 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 229920001282 polysaccharide Polymers 0.000 description 5
- 239000005017 polysaccharide Substances 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 239000003513 alkali Substances 0.000 description 4
- 230000003064 anti-oxidating effect Effects 0.000 description 4
- 230000009466 transformation Effects 0.000 description 4
- 241000287828 Gallus gallus Species 0.000 description 3
- 206010020751 Hypersensitivity Diseases 0.000 description 3
- 206010061598 Immunodeficiency Diseases 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 208000026935 allergic disease Diseases 0.000 description 3
- 230000007815 allergy Effects 0.000 description 3
- 230000002402 anti-lipaemic effect Effects 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 230000003111 delayed effect Effects 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 210000003743 erythrocyte Anatomy 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- RYAHJFGVOCZDEI-UFFNCVEVSA-N Dendrobine Chemical compound C([C@H]1CC[C@@H]2[C@@]31C)N(C)[C@@H]3[C@H]1[C@@H](C(C)C)[C@@H]2C(=O)O1 RYAHJFGVOCZDEI-UFFNCVEVSA-N 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 102000006587 Glutathione peroxidase Human genes 0.000 description 2
- 108700016172 Glutathione peroxidases Proteins 0.000 description 2
- 229920002527 Glycogen Polymers 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 229930013930 alkaloid Natural products 0.000 description 2
- HIMXGTXNXJYFGB-UHFFFAOYSA-N alloxan Chemical compound O=C1NC(=O)C(=O)C(=O)N1 HIMXGTXNXJYFGB-UHFFFAOYSA-N 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- RYAHJFGVOCZDEI-CZKZLRAZSA-N dendrobine Natural products O=C1O[C@@H]2[C@H](C(C)C)[C@H]1[C@H]1[C@@]3(C)[C@@H]2N(C)C[C@H]3CC1 RYAHJFGVOCZDEI-CZKZLRAZSA-N 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 229940096919 glycogen Drugs 0.000 description 2
- 208000019622 heart disease Diseases 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 230000002262 irrigation Effects 0.000 description 2
- 238000003973 irrigation Methods 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 238000001543 one-way ANOVA Methods 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 210000000496 pancreas Anatomy 0.000 description 2
- 150000002989 phenols Chemical class 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- ZWSNUPOSLDAWJS-QNDFHXLGSA-N 6,7-dihydroxy-3-[4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]chromen-4-one Chemical compound OC[C@H]1O[C@@H](Oc2ccc(cc2)-c2coc3cc(O)c(O)cc3c2=O)[C@H](O)[C@@H](O)[C@@H]1O ZWSNUPOSLDAWJS-QNDFHXLGSA-N 0.000 description 1
- HOSGXJWQVBHGLT-UHFFFAOYSA-N 6-hydroxy-3,4-dihydro-1h-quinolin-2-one Chemical group N1C(=O)CCC2=CC(O)=CC=C21 HOSGXJWQVBHGLT-UHFFFAOYSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010010144 Completed suicide Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 235000008440 Crataegus cuneata Nutrition 0.000 description 1
- 244000160089 Crataegus cuneata Species 0.000 description 1
- 235000014283 Crataegus pinnatifida var major Nutrition 0.000 description 1
- IVOMOUWHDPKRLL-KQYNXXCUSA-N Cyclic adenosine monophosphate Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-KQYNXXCUSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- CCEAFOJVRQZWQC-UHFFFAOYSA-N Ddendroxine Natural products CC12C3CCC2CN2CCOC12C1C(C(C)C)C3C(=O)O1 CCEAFOJVRQZWQC-UHFFFAOYSA-N 0.000 description 1
- CCEAFOJVRQZWQC-KFYGABLUSA-N Dendroxine Natural products O=C1O[C@@H]2[C@@H](C(C)C)[C@@H]1[C@H]1[C@]3(C)[C@@H](CN4[C@]23OCC4)CC1 CCEAFOJVRQZWQC-KFYGABLUSA-N 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010049077 Hernia pain Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000004356 Hysteria Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 241001448624 Miliaria Species 0.000 description 1
- 206010028836 Neck pain Diseases 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- MAEQVSBPCIMMJF-UHFFFAOYSA-N Nobilonin Natural products CC(C)C1C2C(=O)C3(C)C(CN(C)C)CCC3C1C(=O)O2 MAEQVSBPCIMMJF-UHFFFAOYSA-N 0.000 description 1
- MAEQVSBPCIMMJF-MSZYXCAISA-N Nobilonine Natural products O=C1[C@@]2(C)[C@@H](CN(C)C)CC[C@H]2[C@H]2[C@H](C(C)C)[C@H]1OC2=O MAEQVSBPCIMMJF-MSZYXCAISA-N 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 241000219100 Rhamnaceae Species 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 240000008866 Ziziphus nummularia Species 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000000496 cardiotonic agent Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000032677 cell aging Effects 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 208000012839 conversion disease Diseases 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- RQFCJASXJCIDSX-UUOKFMHZSA-N guanosine 5'-monophosphate Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O RQFCJASXJCIDSX-UUOKFMHZSA-N 0.000 description 1
- 235000013928 guanylic acid Nutrition 0.000 description 1
- 239000004226 guanylic acid Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000004727 humoral immunity Effects 0.000 description 1
- 239000000864 hyperglycemic agent Substances 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 125000001434 methanylylidene group Chemical group [H]C#[*] 0.000 description 1
- 210000000822 natural killer cell Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 239000003507 refrigerant Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 210000004988 splenocyte Anatomy 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
剂量组(mg/kg.bw) | 动物数(只) | 0小时血糖值(mmol/L) | 0.5小时血糖值(mmol/L) | 2.0小时血糖值(mmol/L) | 血糖曲线下面积 | P值 |
0 | 10 | 15.1±3.4 | 19.7±3.4 | 15.1±3.9 | 34.4±7.2 | |
180 | 10 | 14.6±4.2 | 18.2±4.3 | 14.2±4.3 | 33.1±9.6 | 0.253 |
360 | 10 | 14.3±3.9 | 16.1±4.7 | 14.8±3.6 | 31.8±7.9 | |
720 | 10 | 13.9±3.7 | 15.3±2.2 | 12.1±3.5 | 27.7±5.0 |
剂量组(mg/kg BW) | 动物数(只) | 淋巴细胞增殖能力(OD值) | P值 |
720 | 12 | 1.621±1.192 | 0.001 |
360 | 12 | 0.759±0.178 | 0.413 |
180 | 12 | 0.524±0.212 | 0.906 |
阴性对照 | 12 | 0.415±0.284 | --- |
剂量组(mg/kg BW) | 动物数(只) | 左右耳片重量差值(mg) | P值 |
720 | 12 | 11.70±2.29 | 0.082 |
360 | 12 | 11.26±2.77 | 0.191 |
180 | 12 | 10.54±2.31 | 0.640 |
阴性对照 | 12 | 9.51±1.76 | --- |
剂量组(mg/kgBW) | 动物数(只) | 溶血空斑数(1×103/全脾) | P值 |
720 | 12 | 228.51±26.32 | 0.042 |
360 | 12 | 216.81±21.48 | 0.339 |
180 | 12 | 210.22±29.41 | 0.757 |
阴性对照 | 12 | 202.04±30.33 | --- |
剂量组(mg/kgBW) | 动物数(只) | 抗体积数 | P值 |
720 | 12 | 167.22±18.82 | 0.001 |
360 | 12 | 161.67±16.29 | 0.002 |
180 | 12 | 153.63±22.01 | 0.028 |
阴性对照 | 12 | 133.14±15.37 | --- |
剂量组(mg/kgBW) | 动物数(只) | 吞噬指数 | P值 |
720 | 12 | 10.14±1.01 | 0.001 |
360 | 12 | 9.93±1.43 | 0.008 |
180 | 12 | 8.21±1.38 | 0.683 |
阴性对照 | 12 | 8.02±1.02 | --- |
剂量组(mg/kg BW) | 动物数(只) | 吞噬率(%) | 吞噬指数数据转换 | P值 | 吞噬指数 | P值 |
720 | 12 | 45.42±11.67 | 0.722±0.142 | 0.001 | 0.854±0.394 | 0.001 |
360 | 12 | 37.54±8.86 | 0.657±0.102 | 0.009 | 0.756±0.284 | 0.017 |
180 | 12 | 25.33±8.12 | 0.564±0.086 | 0.723 | 0.503±0.182 | 0.625 |
阴性对照 | 12 | 22.92±9.38 | 0.524±0.096 | --- | 0.378±0.241 | --- |
剂量组(mg/kg BW) | 动物数(只) | NK细胞活性(%) | NK细胞活性数据转换 | P值 |
720 | 12 | 58.51±11.37 | 0.889±0.145 | 0.001 |
360 | 12 | 41.37±10.23 | 0.647±0.136 | 0.001 |
180 | 12 | 27.81±9.17 | 0.553±0.042 | 0.003 |
阴性对照 | 12 | 14.37±11.86 | 0.349±0.167 | --- |
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200910094928XA CN101653249B (zh) | 2009-09-03 | 2009-09-03 | 一种降血糖增强免疫力的功能食品 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200910094928XA CN101653249B (zh) | 2009-09-03 | 2009-09-03 | 一种降血糖增强免疫力的功能食品 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101653249A CN101653249A (zh) | 2010-02-24 |
CN101653249B true CN101653249B (zh) | 2012-08-08 |
Family
ID=41707876
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200910094928XA Expired - Fee Related CN101653249B (zh) | 2009-09-03 | 2009-09-03 | 一种降血糖增强免疫力的功能食品 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101653249B (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103230010A (zh) * | 2013-05-07 | 2013-08-07 | 贵州省赤水市金钗石斛产业开发有限公司 | 一种养胃的金钗石斛口服液 |
CN104920704B (zh) * | 2014-03-21 | 2018-11-06 | 广西玉林容山堂生物科技有限公司 | 一种斛柑茶及其制备方法 |
CN106721740A (zh) * | 2017-01-12 | 2017-05-31 | 广州仁惠经典网络科技有限公司 | 罗勒功能饮料及其制备方法 |
CN108208516A (zh) * | 2018-02-06 | 2018-06-29 | 张艳飞 | 一种固体饮料及其制备方法与应用 |
CN113662113A (zh) * | 2021-08-30 | 2021-11-19 | 中国农业大学 | 一种铁皮石斛雪莲果复合果汁饮品 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1183969A (zh) * | 1996-12-02 | 1998-06-10 | 吕少杰 | 一种治疗糖尿病的中药及其生产方法 |
CN1185913A (zh) * | 1998-01-15 | 1998-07-01 | 郝斌香 | 保健降糖大枣 |
CN101091557A (zh) * | 2006-06-23 | 2007-12-26 | 天津开发区帅嘉商贸行销有限责任公司 | 一种益于糖尿病人服用的食膳 |
CN101249230A (zh) * | 2008-03-31 | 2008-08-27 | 刘广伦 | 一种糖尿病药物及其制备方法 |
CN101444303A (zh) * | 2008-12-10 | 2009-06-03 | 陶国闻 | 石斛葛根杜仲功能食品 |
-
2009
- 2009-09-03 CN CN200910094928XA patent/CN101653249B/zh not_active Expired - Fee Related
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1183969A (zh) * | 1996-12-02 | 1998-06-10 | 吕少杰 | 一种治疗糖尿病的中药及其生产方法 |
CN1185913A (zh) * | 1998-01-15 | 1998-07-01 | 郝斌香 | 保健降糖大枣 |
CN101091557A (zh) * | 2006-06-23 | 2007-12-26 | 天津开发区帅嘉商贸行销有限责任公司 | 一种益于糖尿病人服用的食膳 |
CN101249230A (zh) * | 2008-03-31 | 2008-08-27 | 刘广伦 | 一种糖尿病药物及其制备方法 |
CN101444303A (zh) * | 2008-12-10 | 2009-06-03 | 陶国闻 | 石斛葛根杜仲功能食品 |
Non-Patent Citations (1)
Title |
---|
刘震乙等.消渴证食治要诀刍议.《北京中医》.2000,(第6期),13-14. * |
Also Published As
Publication number | Publication date |
---|---|
CN101653249A (zh) | 2010-02-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104322617B (zh) | 一种辅助降血糖的饼干及其制备方法 | |
CN102907604B (zh) | 一种降糖、降压、减肥、通便养颜、抗疲劳保健品及其生产工艺 | |
CN103734428B (zh) | 一种提高免疫力的女贞子保健茶及其制备方法 | |
CN102613555A (zh) | 一种玛咖粉人参组合物及其制备方法 | |
CN101253903B (zh) | 一种具有减肥功能的保健食品及其制备方法 | |
CN102526478B (zh) | 一种增强免疫力、降血糖功能的保健药物配方 | |
CN103602551B (zh) | 一种有助于消食健胃复方中草药发酵保健酒及其生产方法 | |
CN101579120A (zh) | 一种具有减肥功能的营养食品及其制备方法 | |
CN106266898A (zh) | 一种益气补肾、抗衰老的复方制剂及其制备方法 | |
CN104740308B (zh) | 一种医用生物降血糖口服液及其制备方法 | |
CN104904962A (zh) | 一种绞股蓝复合发酵型中草药保健凉茶 | |
CN104082672B (zh) | 一种具有降血糖功效的养生粥及其制作方法 | |
CN101653249B (zh) | 一种降血糖增强免疫力的功能食品 | |
CN104365943A (zh) | 一种降糖降脂的槐角茶及其制备方法 | |
CN107412665B (zh) | 一种具有解酒、防治酒精性肝损伤的中药组合物及其制备方法和应用 | |
CN103583759A (zh) | 一种绞股蓝中草药保健凉茶 | |
CN103749818A (zh) | 一种黄精降糖降脂保健茶及其制备方法 | |
CN101301427B (zh) | 一种药物组合物及其制备方法和用途 | |
CN104206595A (zh) | 一种降脂降糖的地骨皮保健茶及其制备方法 | |
CN106177477A (zh) | 一种用于降血糖、降血脂和降血压的保健组合物 | |
CN106177432A (zh) | 一种包含青钱柳叶、桑叶、绿茶和玉竹的保健组合物 | |
CN104489172A (zh) | 一种提高免疫力的刺五加保健茶及其制备方法 | |
CN101904501B (zh) | 一种缓解疲劳的功能食品及其制备方法 | |
CN104957515A (zh) | 一种辅助降血糖的馒头及其制备方法 | |
CN108186966A (zh) | 一种预防或改善老年痴呆症的组合物及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: WANG JING Free format text: FORMER OWNER: TAO GUOWEN Effective date: 20141120 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent for invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Wang Jing Inventor before: Tao Guowen |
|
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 650106 KUNMING, YUNNAN PROVINCE TO: 650000 KUNMING, YUNNAN PROVINCE Free format text: CORRECT: INVENTOR; FROM: TAO GUOWEN TO: WANG JING |
|
TR01 | Transfer of patent right |
Effective date of registration: 20141120 Address after: 650000 No. 7, Donghua 30, Donghua District, Guandu District, Yunnan, Kunming Patentee after: Wang Jing Address before: 650106 Yunnan Province, Kunming City Haiyuan Road No. 6 building nine floor high tech investment Patentee before: Tao Guowen |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120808 Termination date: 20190903 |
|
CF01 | Termination of patent right due to non-payment of annual fee |